Condensed Consolidated Statements of Operations and Comprehensive Income (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
Revenues
Gross premiums written	$ 1,748,933		$ 1,871,740
Net premiums written	1,653,215		1,738,494
Increase in unearned premiums	(418,493)		(484,712)
Net premiums earned	1,234,722		1,253,782
Net investment income	104,631		116,867
Net realized and unrealized investment gains	115,645		142,172
Other income	4,292		404
Total revenues	1,459,290		1,513,225
Expenses
Losses and loss expenses and life policy benefits	721,281		749,457
Acquisition costs	275,791		264,608
Other expenses	124,750		111,462
Interest expense	12,245		12,238
Amortization of intangible assets	6,768		7,002
Net foreign exchange gains	(13,147)		(670)
Total expenses	1,127,688		1,144,097
Income before taxes and interest in (losses) earnings of equity method investments	331,602		369,128
Income tax expense	79,665		62,305
Interest in (losses) earnings of equity method investments	(3,838)		6,064
Net income	248,099		312,887
Net income attributable to noncontrolling interests	(2,182)		(3,044)
Net income attributable to PartnerRe Ltd.	245,917		309,843
Preferred dividends	14,184		14,184
Net income attributable to PartnerRe Ltd. common shareholders	231,733		295,659
Comprehensive income
Net income attributable to PartnerRe Ltd.	245,917		309,843
Change in currency translation adjustment	(2,504)		(15,223)
Change in unfunded pension obligation, net of tax	(436)		(1)
Change in unrealized losses on investments, net of tax	(217)		(225)
Total other comprehensive loss, net of tax	(3,157)		(15,449)
Comprehensive income attributable to PartnerRe Ltd.	$ 242,760		$ 294,394
Per share data attributable to PartnerRe Ltd.common shareholders
Basic net income	$ 4.88		$ 5.72
Diluted net income	$ 4.76	[1]	$ 5.61	[1]
Weighted average number of common shares outstanding	47,525,344		51,652,177
Weighted average number of common shares and common share equivalents outstanding	48,710,228		52,727,573
Dividends declared per common share	$ 0.70		$ 0.67

[1] Where the exercise price of share based awards is greater than the average market price of the common shares, the common shares are considered anti-dilutive and are excluded from the calculation of weighted average number of common shares and common share equivalents outstanding - diluted.